Literature DB >> 27034559

Invited Commentary: The specialty of adult congenital heart disease.

Ari M Cedars1.   

Abstract

Entities:  

Year:  2016        PMID： 27034559      PMCID： PMC4790561          DOI： 10.1080/08998280.2016.11929405

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  16 in total

1.  Geriatric congenital heart disease: burden of disease and predictors of mortality.

Authors:  Jonathan Afilalo; Judith Therrien; Louise Pilote; Raluca Ionescu-Ittu; Giuseppe Martucci; Ariane J Marelli
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  ACC 2009 survey results and recommendations: Addressing the cardiology workforce crisis A report of the ACC board of trustees workforce task force.

Authors:  George P Rodgers; Jamie B Conti; Jeffrey A Feinstein; Brian P Griffin; Jerry D Kennett; Svati Shah; Mary Norine Walsh; Eric S Williams; Jeffrey L Williams
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

3.  Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.

Authors:  Mark J Schuuring; Jeroen C Vis; Arie P J van Dijk; Joost P van Melle; Hubert W Vliegen; Petronella G Pieper; Gertjan T Sieswerda; Rianne H A C M de Bruin-Bon; Barbara J M Mulder; Berto J Bouma
Journal:  Eur J Heart Fail       Date:  2013-01-29       Impact factor: 15.534

4.  Congenital heart disease in the general population: changing prevalence and age distribution.

Authors:  Ariane J Marelli; Andrew S Mackie; Raluca Ionescu-Ittu; Elham Rahme; Louise Pilote
Journal:  Circulation       Date:  2007-01-08       Impact factor: 29.690

5.  Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.

Authors:  Anders Hebert; Ulla R Mikkelsen; Ulf Thilen; Lars Idorn; Annette S Jensen; Edit Nagy; Katarina Hanseus; Keld E Sørensen; Lars Søndergaard
Journal:  Circulation       Date:  2014-10-20       Impact factor: 29.690

6.  Specialized adult congenital heart disease care: the impact of policy on mortality.

Authors:  Darren Mylotte; Louise Pilote; Raluca Ionescu-Ittu; Michal Abrahamowicz; Paul Khairy; Judith Therrien; Andrew S Mackie; Ariane Marelli
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

7.  A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot.

Authors:  Kambiz Norozi; Jens Bahlmann; Björn Raab; Valentin Alpers; Jan O Arnhold; Titus Kuehne; Katrin Klimes; Monika Zoege; Siegfried Geyer; Armin Wessel; Reiner Buchhorn
Journal:  Cardiol Young       Date:  2007-06-18       Impact factor: 1.093

8.  Trends in hospitalizations for adults with congenital heart disease in the U.S.

Authors:  Alexander R Opotowsky; Omar K Siddiqi; Gary D Webb
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

9.  ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  J Am Coll Cardiol       Date:  2008-12-02       Impact factor: 24.094

10.  Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.

Authors:  Laura Dos; Sandra Pujadas; Montserrat Estruch; Assumpta Mas; Ignacio Ferreira-González; Antònia Pijuan; Ricard Serra; Jordi Ordóñez-Llanos; Maite Subirana; Guillem Pons-Lladó; Josep R Marsal; David García-Dorado; Jaume Casaldàliga
Journal:  Int J Cardiol       Date:  2013-07-25       Impact factor: 4.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.